Biotechnology And Safety Assessment

Herausgeber: Thomas, J A

• Broschiertes Buch

Produktbeschreibung

Thoroughly updated and revised, this second edition of Biotechnology and Safety Assessment represents a timely update on the rapidly moving field of biopharmaceutics

Produktdetails

• Verlag: CRC Press
• Seitenzahl: 348
• Erscheinungstermin: 18. Dezember 2020
• Englisch
• Abmessung: 234mm x 156mm x 19mm
• Gewicht: 529g
• ISBN-13: 9780367455743
• ISBN-10: 0367455749
• Artikelnr.: 59990093

Autorenporträt

John A. Thomas, Ph.D., is Professor of Pharmacology at the University of Texas Health Science Center at San Antonio. He is the author of over a dozen textbooks and research monographs, including Endocrine Toxicology, Second Edition (Taylor and Francis, 1996). The author of nearly 400 scientific articles in the area of endocrine pharmacology, reproductive toxicology, and drug interactions, Professor Thomas is a well-recognized authority on how drugs and chemicals perturb the endocrine system. He serves on several editorial boards of biomedical journals and is very active among many national and international scientific societies.

Inhaltsangabe

1. Genomic Information - Frontiers of Toxicology J. Beall and M. Stodolsky 2. Antisense Therapeutics S. Crooke 3. Safety Evaluation of Food Crops Developed Through Biotechnology B. Hammond and R. Fuchs 4. Therapeutic Manipulation of Cytokines R. House 5. Triplex and Ribozyme Technology in Gene Repression Y. Lavrovsky
S. Chen and A. Roy 6. Food Allergens - Implications for Biotechnology S. Lehrer and G. Reese 7. The Pharmacokinetics and Toxicity of Phosphorothioate Oligonucleotides A. Levin
R. Geary
J. Leeds
D. Monteith
R. Yu
M. Templin
S. Henry 8. Biotechnology in Agriculture and the Environment - Benefits and Risks C. McCullum
D. Pimentel
M. Paoletti 9. Biotechnology and Risk H. Miller 10. Safety Assessment of Insect-Protected Corn P. Sanders
T. Lee
M. Groth
J. Astwood
R. Fuchs 11. Pharmacology of Recombinant Proteins J. Talmadge 12. Biotechnology - Therapeutic and Nutritional Products J. Thomas 13. Clinical Toxicity of Interferons T. Vial and J. Descotes. of Energy
S. Chen
University of Texas Health Science Centre
USA
S. Crooke
Isis Pharmaceuticals
USA
J. Descotes
Claude Bernard University
France
R. Fuchs
Monsanto
USA
R. Geary
Isis Pharmaceuticals
USA
M. Groth
Monsanto
USA
B. Hammond
Monsanto
USA
S. Henry
Isis Pharmaceuticals
USA
R. House
IIt Research
USA
Y. Lavrovsky
University of Texas Health Science Centre
USA
T. Lee
Monsanto
USA
J. Leeds
Isis Pharmaceuticals
USA
S. Lehrer
Tulane University Medical Centre
USA
A. Levin
Isis Pharmaceuticals
USA
C. McCullum
Cornell University
USA
H. Miller
Stanford University
USA
D. Monteith
Isis Pharmaceuticals
USA
M. Paoletti
Padova University
Italy
D. Pimentel
Cornell University
USA
G. Reese
Tulane University Medical Centre
USA
A. Roy
University of Texas Health Science Centre
USA
P. Sanders
Monsanto
USA
M. Stodolsky
US Department of Energy
J. Talmadge
University of Nebraska Medical Centre
USA
M. Templin
Isis Pharmaceuticals
USA
J. Thomas
Un